A recent study published on June 9, 2026, by Dexcom suggests that their continuous glucose monitoring (CGM) technology can benefit a broader population with diabetes, including those who do not take insulin.[956947][956046] According to researchers, this could lead to better insurance coverage for CGM devices, making them more accessible to people who do not take insulin.[956947]